Publication | Closed Access

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

Zoledronic AcidUrologyRadiation MedicineTrog 03.04Radiation TherapyMedicineFactorial TrialProstatic DiseaseOncologyRadiation Oncology